ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

21 - 40 out of 593 results.

SCIESCOPUS
Organ-specific responses to nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma: A multicenter, retrospective study.

Kim, Youngun; Kim, Jung Sun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; Lee, Won Suk; Jung, Sanghoon; An, Chansik; Kim, Han Sang; Kim, Chang Gon, et al.

ArticleIssue Date2025CitationJOURNAL OF CLINICAL ONCOLOGY, v.43, no.4_SUPPL, pp 543 - 543PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Updated results from the trastuzumab deruxtecan (T-DXd) 5.4 mg/kg triplet combination of DESTINY-Gastric03 (DG-03): First-line (1L) T-DXd with fluoropyrimidine (FP) and pembrolizumab in advanced/metastatic HER2-positive (HER2+) esophageal adenocarcinoma, gastric cancer (GC), or gastroesophageal junction adenocarcinoma (GEJA).

Janjigian, Yelena Y.; Van Laarhoven, Hanneke W. M.; Rha, Sun Young; Kozlov, Vadim; Oh, Do-Youn; Gravina, Adriano; Rapatoni, Liane; Shoji, Hirokazu; Hofheinz, Ralf Dieter; Chen, Li-Tzong, et al.

ArticleIssue Date2025CitationJOURNAL OF CLINICAL ONCOLOGY, v.43, no.4_SUPPL, pp 448 - 448PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Final analysis of the randomized phase 2 part of the ASPEN-06 study: A phase 2/3 study of evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with HER2-overexpressing gastric/gastroesophageal cancer (GC).

Shitara, Kohei; Wainberg, Zev A.; Tabernero, Josep; Van Cutsem, Eric; Coutzac, Clelia; De La Fouchardiere, Christelle; Lee, Jeeyun; Rha, Sun Young; Kang, Yoon-Koo; Fanning, Philip, et al.

ArticleIssue Date2025CitationJOURNAL OF CLINICAL ONCOLOGY, v.43, no.4_SUPPL, pp 332 - 332PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Ahn, Myung-Ju; Tanaka, Kentaro; Paz-Ares, Luis; Cornelissen, Robin; Girard, Nicolas; Pons-Tostivint, Elvire; Vicente Baz, David; Sugawara, Shunichi; Cobo, Manuel; Pérol, Maurice, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.3PublisherLippincott Williams and Wilkins
SCIESCOPUS
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study

"Montagna, Giacomo; Laws, Alison; Ferrucci, Massimo; Mrdutt, Mary M.; Sun, Susie X.; Bademler, Suleyman; Balbaloglu, Hakan; Balint-Lahat, Nora; Banys-Paluchowski, Maggie; Barrio, Andrea V., et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.43, no.7, pp 810 - 820PublisherLippincott Williams and Wilkins
SCIESCOPUS
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Studyopen access

Leighl, Natasha B.; Akamatsu, Hiroaki; Lim, Sun Min; Cheng, Ying; Minchom, Anna R.; Marmarelis, Melina E.; Sanborn, Rachel E.; Chih-Hsin Yang, James; Liu, Baogang; John, Thomas, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.30, pp 3593 - 3605PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274

Galsky, Matthew D.; Witjes, Johannes Alfred; Gschwend, Jürgen E.; Milowsky, Matthew I.; Schenker, Michael; Valderrama, Begoña P.; Tomita, Yoshihiko; Bamias, Aristotelis; Lebret, Thierry; Shariat, Shahrokh F., et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.43, no.1, pp 15 - 21PublisherLippincott Williams and Wilkins
SCIESCOPUS
Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial

Kang, Danbee; Cho, Juhee; Zhao, Di; Kim, Jeonghyun; Kim, Nayeon; Kim, Hoyoung; Kim, Sooyeon; Kim, Ji-Yeon; Park, Yeon Hee; Im, Young Hyuck, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.26, pp 3115 - 3122PublisherLippincott Williams and Wilkins
SCIESCOPUS
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis with Efficacy Update

Loibl, Sibylle; Jassem, Jacek; Sonnenblick, Amir; Parlier, Damien; Winer, Eric; Bergh, Jonas; Gelber, Richard D.; Restuccia, Eleonora; Im, Young-Hyuck; Huang, Chiun-Sheng, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.31, pp 3643 - 6351PublisherLippincott Williams and Wilkins
SCIESCOPUS
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.

Choi, Hea Lim; Kim, Bongsung; Han, Kyungdo; Shin, Dong Wook

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.23_SUPPL, pp 19 - 19PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients with Leptomeningeal Metastases Associated with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)open access

Park, Sehhoon; Baldry, Richard; Jung, Hyun Ae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Kim, Yu Jung; Lee, Youngjoo; Kim, Dong-Wan; Kim, Sang-We, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.23, pp 2747 - 2756PublisherLippincott Williams and Wilkins
SCIESCOPUS
Lymphoma Classifications, How to Develop a Future Unified Taxonomy

Campo, Elias; Dierickx, Daan; Dirnhofer, Stefan; Dunleavy, Kieron; Gaulard, Philippe; Hasserjian, Robert P.; Jaffe, Elaine S.; Kim, Won Seog; King, Rebecca L.; Lim, Megan S., et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.27, pp 3177 - 3182PublisherLippincott Williams and Wilkins
SCIESCOPUS
Durable Responses with Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Studyopen access

Budde, Lihua E.; Assouline, Sarit; Sehn, Laurie H.; Schuster, Stephen J.; Yoon, Sung-Soo; Yoon, Dok Hyun; Matasar, Matthew J.; Bosch, Francesc; Kim, Won Seog; Nastoupil, Loretta J., et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.19, pp 2250 - 2256PublisherLippincott Williams and Wilkins
SCIESCOPUS
A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.

Sohn, Joohyuk; Kim, Gun Min; Jung, Kyung Hae; Jeung, Hei-Cheul; Lee, Jieun; Lee, Keun Seok; Im, Seock-Ah; Kang, Seok Yun; Kim, Se Hyun; Kim, Han Jo, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.17_SUPPL, pp LBA502 - LBA502PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2-metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

Park, Yeon Hee; Lee, Kyung-Hun; Kim, Gun Min; Kang, Seok Yun; Lee, Keun Seok; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee Jun, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.17_SUPPL, pp LBA1002 - LBA1002PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

Camidge, D. Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Ciuleanu, Tudor; Daaboul, Nathalie; Liu, Chunling, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.25, pp 3000 - 3011PublisherLippincott Williams and Wilkins
SCIESCOPUS
Comparison of machine learning algorithms for the radiomic classification of gastric subepithelial tumors

Jeong, Woo Kyoung; Lee, Jeong Hyun

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Deep learning-based chest CT model to predict treatment response to immune checkpoint inhibitors in non-small cell lung cancer independently and additively to histopathological biomarkers

Ahn, Chang Ho; Jeong, Dong Young; Moon, Jimin; Park, Jongchan; Shin, Jisoo; Lee, Seungje; Lim, Yoojoo; Park, Sehhoon; Lee, Sehoon; Ock, Chan-Young, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Association between homologous recombination deficiency (HRD) gene mutations and the efficacy of venadaparib in combination with irinotecan as third- or fourth-line treatment in patients with metastatic gastric cancer (mGC)

Ryu, Min-Hee; Kim, Hyung-Don; Oh, Do-Youn; Lee, Keun-Wook; Rha, Sun Young; Kim, Seung Tae; Lee, Won Sik; Hong, Min Ju; Lee, Myongjae; Roh, Eun-Jihn, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pretreated advanced biliary tract cancer: Efficacy and safety analysis (BOLD-100-001).

O'Kane, Grainne M.; Oh, Do-Youn; Spratlin, Jennifer; Rha, Sun Young; Elimova, Elena; Kavan, Petr; Goodwin, Rachel Anne; Cha, Yongjun; Kim, Seung Tae; McAllister, E. Russell, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어